e-ISSN 1694-2078
p-ISSN 1694-2086
  

Arch Med Biomed Res. 2014;1:1-9.

Arun K Agnihotri1, Theeshan Bahorun2, Okezie I Aruoma3

Author Affiliations

1Department of Forensic Medicine and Toxicology, SSR Medical College, Mauritius
2ANDI Centre of Excellence for Biomedical and Biomaterials Research, University of Mauritius, Mauritius
3Department of Pharmaceutical Sciences, School of Pharmacy, American University of Health Sciences, Signal Hill, California, USA

correspondence to
AK Agnihotri; agnihotri_arun@hotmail.com
OI Aruoma; oaruoma@auhs.edu
T Bahorun; tbahorun@uom.ac.mu

Received: February 7, 2014
Revised: March 18, 2014
Accepted: March 20, 2014

Abstract

Chemotherapy to patients with cancer remains an effective mode of treatment of the disease, but it is associated with many side effects including mild or dose-limiting toxicities such as alopecia, myelosuppression, gastrointestinal dysfunctions, neurologic toxicities, and immune suppression which results in infections and cancer cell proliferation. Although economic analysis of treatment in health care systems may be applied to the full range of interventions that make up a cancer service, the economic impact of cancer in health care systems remains one where much attention, in the context of complementary medicine, needs to be directed. Predicting the cost-effectiveness of developing prevention, screening and treatment strategies continue to be the focus strategies to optimize cancer care.

KEY WORDS: Cancer; Global health perspectives; Palliative care; Stem cell cancer; Dietary components and chemoprevention

 
    
   
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.